These findings suggest that COVID-19 vaccination is not associated with changes in ovarian reserve by multiple biomarker assays of AMH and AFC, supporting previous studies on AMH.3,4,5 The AMH difference was not clinically significant on subgroup analysis. The gene discussed is AMH; the disease is COVID-19.